NCT03593590 Non-interventional Study of Ocrelizumab in Participants With Relapsing or Primary Progressive Multiple Sclerosis Status COMPLETED Phase N/A
NCT03589105 A Study to Provide Complementary Efficacy, Safety and Patient Reported Outcomes Data in Participants With Active Relapsing Forms of Multiple Sclerosis (MS) in a Pragmatic Setting Status COMPLETED Phase PHASE4
NCT03586726 A Study to Investigate the Effect of Rifampicin on the PK of Multiple Doses of Balovaptin In Healthy Volunteers Status COMPLETED Phase PHASE1
NCT03584009 A Phase II Study Comparing The Efficacy Of Venetoclax + Fulvestrant Vs. Fulvestrant In Women With Estrogen Receptor-Positive, Her2-Negative Locally Advanced Or Metastatic Breast Cancer Who Experienced Disease Recurrence Or Progression During Or After CDK4/6 Inhibitor Therapy Status TERMINATED Phase PHASE2
NCT03579719 A Study to Investigate the Effect of Itraconazole on the PK of Multiple Doses of Balovaptan in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT03570658 A Double-Blind Single-Ascending Dose (SAD) and Multiple-Ascending Dose (MAD) Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7049389 in Healthy Chinese Participants Status COMPLETED Phase PHASE1
NCT03559647 The Effectiveness Of Atezolizumab In Patients With Locally-Advanced Or Metastatic Non-Small Cell Lung Cancer After Prior Chemotherapy Status COMPLETED Phase N/A
NCT03558490 A Study to Assess the Feasibility of an E-Health System (ZEMY) Designed to Manage Symptoms in Participants With Breast Cancer Under Anti-Cancer Treatment Status COMPLETED Phase PHASE2
NCT03556839 Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the Cervix Status COMPLETED Phase PHASE3
NCT03555149 A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Metastatic Colorectal Cancer (Morpheus-CRC) Status TERMINATED Phase PHASE1/PHASE2
NCT03552393 Ascertain the Optimal Starting Dose of Mircera Given Subcutaneously for Maintenance Treatment of Anemia in Pediatric Patients With Chronic Kidney Disease on Dialysis or Not Yet on Dialysis. Status COMPLETED Phase PHASE2
NCT03539484 A Study of RO7172508 in Patients With Locally Advanced and/or Metastatic CEA-Positive Solid Tumors Status TERMINATED Phase PHASE1
NCT03533283 An Open-Label Phase lB/II Study of Glofitamab and Atezolizumab or Polatuzumab Vedotin in Adult Patients With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03530917 A Study to Assess the Safety and Tolerability of Single and Multiple Ascending Doses of Oral RO7020531 in Chinese Healthy Participants. Status COMPLETED Phase PHASE1
NCT03523858 A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03507569 Open Label, Adaptive, Parallel Group PET Study Using RO7017773 And [11C] RO15-4513 Status COMPLETED Phase PHASE1
NCT03505190 A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of RO7062931 in Healthy Chinese Volunteers. Status COMPLETED Phase PHASE1
NCT03504917 A Study of Balovaptan in Adults With Autism Spectrum Disorder With a 2-Year Open-Label Extension Status TERMINATED Phase PHASE3
NCT03498716 A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer Status TERMINATED Phase PHASE3
NCT03498521 A Phase II Randomized Study Comparing the Efficacy and Safety of Targeted Therapy or Cancer Immunotherapy Versus Platinum-Based Chemotherapy in Patients With Cancer of Unknown Primary Site Status COMPLETED Phase PHASE2